Evidence map›Paper›PMID 33437944›Full record

ArticleiScience2021

Impaired endoplasmic reticulum-mitochondrial signaling in ataxia-telangiectasia.

Abrey J Yeo, Kok L Chong, Magtouf Gatei, Dongxiu Zou, Romal Stewart, Sarah Withey, Ernst Wolvetang, Robert G Parton, Adam D Brown, Michael B Kastan and 2 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in iScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04513002 phase2completednot on this mapstarted 2022, after this paper: background citation

A Phase 2A/2B Placebo-controlled Randomised Clinical Trial to Test the Ability of Triheptanoin to Protect Primary Airway Epithelial Cells Obtained From Participants With Ataxia-telangiectasia Against Death Induced by Glucose Deprivation

TypeinterventionalSponsorThe University of QueenslandRan2022 to 2023Enrolled30ConditionsAtaxia TelangiectasiaArmsTriheptanoin
NCT06324877 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Single Arm Open-label Clinical Trial in Ataxia-telangiectasia to Test the Effects of Nicotinamide Riboside on Ataxia Scales, Immune Function, and Neurofilament Light Chain.

TypeinterventionalSponsorThe University of QueenslandRan2024 to 2025Enrolled10ConditionsAtaxia TelangiectasiaArmsNicotinamide riboside
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Stem cell models in ataxia-telangiectasia.Neural regeneration research · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. ATM interaction with GRP94 modulates oncogenic receptor expression and signaling and microglial activation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors.International journal of molecular sciences · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Abrey J YeoUniversity of Queensland Centre for Clinical Research, The University of Queensland, Herston, Brisbane, Australia.
Kok L ChongUniversity of Queensland Centre for Clinical Research, The University of Queensland, Herston, Brisbane, Australia.
Magtouf GateiUniversity of Queensland Centre for Clinical Research, The University of Queensland, Herston, Brisbane, Australia.
Dongxiu ZouUniversity of Queensland Centre for Clinical Research, The University of Queensland, Herston, Brisbane, Australia.
Romal StewartQIMR Berghofer, Herston, Brisbane, Australia.
Sarah WitheyAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Brisbane, Australia.
Ernst WolvetangAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Brisbane, Australia.
Robert G PartonInstitute for Molecular Bioscience and Centre for Microscopy and Microanalysis, The University of Queensland, St Lucia, Brisbane, Australia.
Adam D BrownDuke University School of Medicine, Durham, NC, USA.
Michael B KastanDuke University School of Medicine, Durham, NC, USA.
David ComanQueensland Children's Hospital, Brisbane, Australia.
Martin F LavinUniversity of Queensland Centre for Clinical Research, The University of Queensland, Herston, Brisbane, Australia.
The University of Queensland · AUDuke University · USChildren's Health Queensland Hospital and Health Service · AUQIMR Berghofer Medical Research Institute · AU

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI JOHN N. NORTON · 1985 to 2026
$174.8M
The role of ATM in Metabolic Stress ResponsesR01CA157216 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KASTAN, MICHAEL B · 2011 to 2020
$3.1M
NCI NIH HHS P30 CA014236NCI NIH HHS R01 CA157216
6 · The paper itself

Abstract

There is evidence that ATM mutated in ataxia-telangiectasia (A-T) plays a key role in protecting against mitochondrial dysfunction, the mechanism for which remains unresolved. We demonstrate here that ATM-deficient cells are exquisitely sensitive to nutrient deprivation, which can be explained by defective cross talk between the endoplasmic reticulum (ER) and the mitochondrion. Tethering between these two organelles in response to stress was reduced in cells lacking ATM, and consistent with this, Ca

Indexed as

Cell BiologyFunctional Aspects of Cell BiologyOrganizational Aspects of Cell Biology

Identifiers

PMID33437944
PMCPMC7788243
OpenAlexW3116066734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.